Invest now
Indegene share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹570.55(0.96%)August 13, 2026 11:09:43 AM IST
- NSE
- BSE
- Vol : 113.67 K (NSE + BSE)Last 20 day avg : 759.30 K
Indegene is trading 0.96% upper at Rs 570.55 as compared to its last closing price. Indegene has been trading in the price range of 574.10 & 566.10. Indegene has given 8.64% in this year & 4.65% in the last 5 days. Indegene has TTM P/E ratio 31.44 as compared to the sector P/E of 49.75.There are 6 analysts who have initiated coverage on Indegene. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 116.20 Crores in its last quarter.Listed peers of Indegene include Delhivery (-0.76%), Urban Company (3.63%), BLS International Services (1.14%).The Mutual Fund holding in Indegene was at 5.28% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Indegene was at 9.92% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 13 Aug 2026, 11:14 AM IST
- Debt To EquityIn line with industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.40Annual dividends as a percentage of the stock price.
- P/BLower than historical values4.35The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values34.15Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation2.35The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Indegene News
Indegene Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Delhivery | 467.60 | -0.76 | 35,025.79 | 226.01 | 3.8 | - | 11.56 |
| Urban Company | 144.00 | 3.63 | 22,360.28 | - | 8.89 | - | 4.87 |
| BLS International Services | 266.00 | 1.14 | 10,910.83 | 14.15 | 3.94 | 0.95 | 13.29 |
| Axiscades Technologies | 1,534.95 | -0.62 | 6,510.34 | 83.28 | 9.05 | - | 23.13 |
| TVS Supply Chain Solutions | 128.40 | -0.43 | 5,662.56 | 26.67 | 2.95 | - | 63.67 |
Mutual Fund Ownership
View allIndegene Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-29 | Quarterly Results & ESOP |
| 2025-10-30 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
About the company Indegene
- IndustryBusiness Services
- ISININE065X01017
- BSE Code544172
- NSE CodeINDGN
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
Indegene Share Price FAQs
Indegene is trading at 570.55 as on Thu Aug 13 2026 05:39:43. This is 0.96% upper as compared to its previous closing price of 565.10.
The market capitalization of Indegene is 13655.82 Cr as on Thu Aug 13 2026 05:39:43.
The average broker rating on Indegene is Hold. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 3 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Indegene is 596.50 whereas the 52 wk low is 414.90
Indegene can be analyzed on the following key metrics -
- TTM P/E: 31.44
- Sector P/E: 49.75
- Dividend Yield: 0.40%
- D/E ratio: -
Indegene reported a net profit of 401.10 Cr in 2026.
The Mutual Fund Shareholding was 5.28% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Indegene QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.